Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
Pharming Group N.V. For media and investors only Researchers identified variants which may cause activated phosphoinositide 3-kinase delta…